CMS Reviewing Medtronic Activa Reimbursement For Bilateral Indication

The Centers for Medicare & Medicaid Services has initiated a national coverage review of Medtronic's Activa for bilateral brain stimulation in Parkinson's disease patients, but the agency will not reimburse the indication until it is approved by FDA.